Citation Tools

Original research
Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors

Download to a citation manager

Cite this article as:
Papadatos-Pastos D, Yuan W, Pal A, et al
Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors